SelectScience InterviewsLife Sciences

Fractionation of Cellular Exosomes for Anti-Cancer Therapeutics

19 Dec 2018
Fractionation of Cellular Exosomes for Anti-Cancer Therapeutics

Prof. Steve Conlan, Director of Innovation and head of the Reproductive Biology and Gynecological Oncology research group at Swansea University Medical School discusses the technology behind exosome production and purification platforms. Cellular exosomes may present a biopharmaceutical option for the study of cancer diagnostics and therapeutics, and the development of 3D cell cultures systems to test these new therapeutics.

About the company

SelectScience logo

SelectScience

Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.

Other videos from SelectScience

Links

Fractionation of Cellular Exosomes for Anti-Cancer Therapeutics